DSM: shares rise after solid Q3.
(CercleFinance.com) - On Thursday DSM shares are up over 1% on Euronext Amsterdam, after the Dutch supplements maker reported better-than-expected Q3 results.
The company - which recently filed a lawsuit against three Chinese chemical companies for patent infringement relating to amoxicillin - posted Q3 earnings of 1.3 billion euros, up from 322 million euros a year ago.
This quadrupling of the result is mainly due to the sale of its share in Patheon, which DSM completed in August and which raised 1.25 billion euros.
Adjusted Ebitda and sales were up 13% and 7% to resepctively to 365 million and 2.14 billion euros, compared to consensus of 351 million and 2.08 billion euros.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The company - which recently filed a lawsuit against three Chinese chemical companies for patent infringement relating to amoxicillin - posted Q3 earnings of 1.3 billion euros, up from 322 million euros a year ago.
This quadrupling of the result is mainly due to the sale of its share in Patheon, which DSM completed in August and which raised 1.25 billion euros.
Adjusted Ebitda and sales were up 13% and 7% to resepctively to 365 million and 2.14 billion euros, compared to consensus of 351 million and 2.08 billion euros.
Copyright (c) 2017 CercleFinance.com. All rights reserved.